Welcome to FZATA
FZata is a pre-clinical stage biotech company with a focus on developing antibody-based therapeutics with our proprietary platforms. FZata has generated a pipeline targeting at gastrointestinal related infectious, inflammatory and metabolic diseases. Our mission is to create innovative medicines that make a real difference to health.
Research article on FZ002 was published in Science Translational Medicine
November 6, 2020
FZata received SBIR Fast-track grant.
August 1, 2020
FZata is spotlighted!
July 31, 2020
BioBuzz Newsletter- June 2019
May 27, 2020
FZata the Recipient of Two Additional SBIR Grants in 2...
February 8, 2018
FZata Honored as Best Life Sciences Company 2017
December 28, 2017